Refresh

SMS Pharmaceuticals Ltd. - Research Center

532815 SMSPHARMA Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20 Mar ' 19
Income

Operating income

522.05 519.87 563.18 411.95 464.91
Expenses

Material consumed

341.38 282.10 345.37 251.38 297.74

Manufacturing expenses

51.55 48.23 34.02 28.62 29.81

Personnel expenses

55.04 51.02 41.17 39.35 35.59

Selling expenses

- - - - 0.63

Adminstrative expenses

19.37 24.03 21.50 12.68 11.04

Expenses capitalised

- - - - -

Cost of sales

467.35 405.39 442.07 332.03 374.81

Operating profit

54.70 114.48 121.11 79.92 90.10

Other recurring income

4.89 5.20 3.45 5.11 3.40

Adjusted PBDIT

59.59 119.68 124.56 85.03 93.50

Financial expenses

21.92 18.88 11.16 12.21 11.87

Depreciation

32.13 32.15 22.28 22.07 19.27

Other write offs

- - - - -

Adjusted PBT

5.55 68.65 91.12 50.76 62.35

Tax charges

1.47 0.62 30.16 18.07 20.90

Adjusted PAT

4.08 68.04 60.96 32.69 41.45

Non recurring items

-0.21 0.04 -0.16 -0.09 -0.08

Other non cash adjustments

- - - - -

Reported net profit

3.88 68.08 60.80 32.60 41.37

Earnigs before appropriation

324.76 333.42 275.35 229.65 209.60

Equity dividend

2.54 2.54 - 5.10 2.55

Preference dividend

- - - - -

Dividend tax

- - - - -

Retained earnings

322.22 330.88 275.35 224.55 207.05
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com